Ruth D. Etzioni
Program in Biostatistics
Division of Public Health Sciences
Fred Hutchinson Cancer Research Center
Seattle
USA
Name/email consistency: high
- Increasing use of radical prostatectomy for nonlethal prostate cancer in Sweden. Etzioni, R., Mucci, L., Chen, S., Johansson, J.E., Fall, K., Adami, H.O. Clin. Cancer Res. (2012)
- The prostate cancer conundrum revisited : Treatment changes and prostate cancer mortality declines. Etzioni, R., Gulati, R., Tsodikov, A., Wever, E.M., Penson, D.F., Heijnsdijk, E.A., Katcher, J., Draisma, G., Feuer, E.J., de Koning, H.J., Mariotto, A.B. Cancer (2012)
- Quantifying the role of PSA screening in the US prostate cancer mortality decline. Etzioni, R., Tsodikov, A., Mariotto, A., Szabo, A., Falcon, S., Wegelin, J., DiTommaso, D., Karnofski, K., Gulati, R., Penson, D.F., Feuer, E. Cancer. Causes. Control (2008)
- Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach. Etzioni, R., Gulati, R., Falcon, S., Penson, D.F. Med. Decis. Making (2008)
- Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence. Etzioni, R.D., Ankerst, D.P., Weiss, N.S., Inoue, L.Y., Thompson, I.M. J. Natl. Cancer Inst. (2007)
- Analyzing patterns of staining in immunohistochemical studies: application to a study of prostate cancer recurrence. Etzioni, R., Hawley, S., Billheimer, D., True, L.D., Knudsen, B. Cancer Epidemiol. Biomarkers Prev. (2005)
- Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial. Etzioni, R.D., Howlader, N., Shaw, P.A., Ankerst, D.P., Penson, D.F., Goodman, P.J., Thompson, I.M. J. Urol. (2005)
- Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: do combination tests improve detection?. Etzioni, R., Falcon, S., Gann, P.H., Kooperberg, C.L., Penson, D.F., Stampfer, M.J. Cancer Epidemiol. Biomarkers Prev. (2004)
- The case for early detection. Etzioni, R., Urban, N., Ramsey, S., McIntosh, M., Schwartz, S., Reid, B., Radich, J., Anderson, G., Hartwell, L. Nat. Rev. Cancer (2003)
- Combining biomarkers to detect disease with application to prostate cancer. Etzioni, R., Kooperberg, C., Pepe, M., Smith, R., Gann, P.H. Biostatistics (2003)
- Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. Etzioni, R., Penson, D.F., Legler, J.M., di Tommaso, D., Boer, R., Gann, P.H., Feuer, E.J. J. Natl. Cancer Inst. (2002)
- Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. Etzioni, R., Legler, J.M., Feuer, E.J., Merrill, R.M., Cronin, K.A., Hankey, B.F. J. Natl. Cancer Inst. (1999)